Robert C. Minnee

Robert C. Minnee

Auto-generated profile, based on publicly available information

Robert C. Minnee

Division of HPB and Transplant Surgery, Department of Surgery Erasmus MC Transplant Institute, Erasmus Medical Center Rotterdam the Netherlands

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in International Journal of Surgery
Verified
Journal Article
Open access
ERElsaline Rijkse
Elsaline Rijkse
SCSebastiaan Ceuppens
Sebastiaan Ceuppens
HQHongchao Qi
Hongchao Qi
JIJan N.M. Ijzermans
Jan N.M. Ijzermans
DHDennis A. Hesselink
Dennis A. Hesselink
RMRobert C. Minnee
Robert C. Minnee
Donation after circulatory death (DCD) kidney transplantation has been introduced to address organ shortage. However, DCD kidneys are not accepted worldwide due to concerns about inferior quality. To investigate whether these concerns are justified, we performed a systematic review and meta-analysis to investigate DCD graft outcomes compared to donation after brain death (DBD). EMBASE, Medline, Cochrane, Web of Science and Google Scholar were searched from database inception until September 2020. Exclusion criteria were studies reporting on pediatric/dual kidney transplants, multi-organ transplants or studies including normothermic perfusion techniques. The primary outcome was graft survival. Secondary outcomes were primary non-function (PNF), delayed graft function (DGF), 3-months biopsy-proven acute rejection (BPAR), 1-year estimated Glomerular Filtration Rate (eGFR), patient survival, and urologic complications. A random-effects model was used for meta-analysis. Meta-regression analysis was performed in case of high between-study heterogeneity. Fifty-one studies were included, comprising 73,454 DCD and 518,229 DBD recipients. One-year graft loss was increased in DCD recipients (death-censored: risk ratio (RR) 1.10 (95%-confidence interval (CI) 1.04-1.16), all-cause: RR 1.13 (95%-CI 1.08-1.19)). Ten-year graft loss was similar to DBD (death-censored: RR 1.02 (95%-CI 0.92-1.13), all-cause: RR 1.03 (95%-CI 0.94-1.13)). DCD recipients had an increased risk of PNF (RR 1.43 (95%-CI 1.26-1.62)), DGF (RR 2.02 (95%-CI 1.88-2.16)), and 1-year mortality (RR 1.10 (95%-CI 1.01-1.21)). No differences were observed for 3-months BPAR, ureter stenosis/leakage, 1-year eGFR and 10-year mortality. Long-term DCD kidney transplant outcomes are similar to DBD despite a higher risk of PNF, DGF, and a 13% increased risk of graft loss in the first year after transplantation. These results should encourage implementation of DCD programs.

8 January 2021 in BJS Open
Verified
Journal Article
Open access
PDF file
ERElsaline Rijkse
Elsaline Rijkse
JJJ de Jonge
J de Jonge
HKH J A N Kimenai
H J A N Kimenai
MHM J Hoogduijn
M J Hoogduijn
RBR W F de Bruin
R W F de Bruin
RMR C Minnee
R C Minnee
The 5-year graft survival rate of donor kidneys transplanted in the Eurotransplant Senior Program (ESP) is only 47 per cent. Normothermic machine perfusion (NMP) may be a new preservation technique that improves graft outcome. This pilot study aimed to assess safety and feasibility of this technique within the ESP. Recipients were eligible for inclusion if they received a donor kidney within the ESP. Donor kidneys underwent 2 h of oxygenated NMP with a red cell-based solution at 37°C, additional to standard-of-care preservation (non-oxygenated hypothermic machine perfusion). The primary outcome was the safety and feasibility of NMP. As a secondary outcome, graft outcome was investigated and compared with that in a historical group of patients in the ESP and the contralateral kidneys. Eleven patients were included in the NMP group; the function of eight kidneys could be compared with that of the contralateral kidney. Fifty-three patients in the ESP, transplanted consecutively between 2016 and 2018, were included as controls. No adverse events were noted, especially no arterial thrombosis or primary non-function of the transplants. After 120 min of oxygenated NMP, median flow increased from 117 (i.q.r. 80–126) to 215 (170–276) ml/min (P = 0.001). The incidence of immediate function was 64 per cent in the NMP group and 40 per cent in historical controls (P = 0.144). A significant difference in graft outcome was not observed. This pilot study showed NMP to be safe and feasible in kidneys transplanted in the ESP. A well powered study is warranted to confirm these results and investigate the potential advantages of NMP on graft outcome.

18 January 2020 in World Journal of Transplantation
Verified
Journal Article
Open access
ERElsaline Rijkse
Elsaline Rijkse
JIJan Nm Ijzermans
Jan Nm Ijzermans
RMRobert C Minnee
Robert C Minnee
Machine perfusion in abdominal organ transplantation: Current use in the Netherlands

4 March 2020 in Transplant International
Verified
Journal Article
Open access
PDF file
ERElsaline Rijkse
Elsaline Rijkse
JDJacob L. Dam
Jacob L. Dam
JRJoke I. Roodnat
Joke I. Roodnat
HKHendrikus J. A. N. Kimenai
Hendrikus J. A. N. Kimenai
Jan IJzermansJan IJzermans
Jan IJzermans
RMRobert C. Minnee
Robert C. Minnee
The prognosis of kidney transplant recipients (KTR) with vascular calcification (VC) in the aorto‐iliac arteries is unclear. We performed a systematic review and meta‐analysis to investigate their survival outcomes. Studies from January 1st, 2000 until March 5th, 2019 were included. Outcomes for meta‐analysis were patient survival, (death‐censored) graft survival and delayed graft function (DGF). Twenty‐one studies were identified, 8 provided data for meta‐analysis. KTR with VC had a significantly increased mortality risk (1‐year: risk ratio (RR) 2.19 (1.39‐3.44), 5‐year: RR 2.28 (1.86‐2.79)). The risk of 1‐year graft loss was 3 times higher in recipients with VC (RR 3.15 (1.30‐7.64)). The risk of graft loss censored for death (1‐year: RR 2.26 (0.58‐2.73), 3‐year: RR 2.19 (0.49‐9.82)) and the risk of DGF (RR 1.24, 95% CI 0.98‐1.58) were not statistically different. The quality of the evidence was rated as very low. To conclude, the presence of VC was associated with an increased mortality risk and risk of graft loss. In this small sample size, no statistical significant association between VC and DGF or risk of death‐censored graft loss could be demonstrated. For interpretation of the outcomes, the quality and sample size of the evidence should be taken into consideration.

23 September 2009 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
RMRobert C. Minnee
Robert C. Minnee
FBFrederike J. Bemelman
Frederike J. Bemelman
PPPilar P. Laguna Pes
Pilar P. Laguna Pes
IBIneke J. M. Ten Berge
Ineke J. M. Ten Berge
DLDink A. Legemate
Dink A. Legemate
MIMirza M. Idu
Mirza M. Idu
Background: Ureteral stents are successful in reducing urological complications after renal transplantation. However, the optimal duration and method of stenting have not yet been clarified. The objective of the present study was to investigate the frequency of urological complications when a 5‐day external stented ureterocystostomy protocol was followed.Methods: A single‐center nonrandomized analysis of 392 kidney transplantations between June 2003 and June 2007 was conducted. From July 2005 all 196 renal transplant recipients received a 5‐day external stented ureterocystostomy. A urological complication was defined as any cause leading to the placement of a percutaneous nephrostomy catheter and/or surgical revision of the ureterocystostomy.Results: In the non‐stented group, 21 of the 196 patients (10.7%) developed a urological complication compared to 13 patients (6.6%) in the stented group (p = 0.151). In the stented group, 2 of the 66 recipients of a living donor transplant (3.0%) developed a urological complication compared to 8 of the 59 recipients (13.6%) in the non‐stented group (P = 0.030). Eleven of 130 recipients of a deceased donor transplant (8.5%) in the stented group developed a urological complication, compared to 13 of the 137 recipients (9.5%) in the non‐stented group (P = 0.769). The surgical revision rate of the stented and the non‐stented group was 5/13 39% and 6/21 29%, respectively.Conclusions: A 5‐day routine external stent protocol is efficacious in living donor renal transplantation in preventing early postoperative ureter obstruction, but this stenting period seems inadequate for deceased donor renal transplantation.

1 January 2021 in International Journal of Surgery Protocols
Verified
Journal Article
Open access
PDF file
ERElsaline Rijkse
Elsaline Rijkse
SBSarah Bouari
Sarah Bouari
HKHendrikus J. A. N. Kimenai
Hendrikus J. A. N. Kimenai
JJJeroen de Jonge
Jeroen de Jonge
RBRon W. F. De Bruin
Ron W. F. De Bruin
RMRobert C. Minnee
Robert C. Minnee
: Introduction: Ageing of the general population has led to an increase in the use of suboptimal kidneys from expanded criteria donation after brain death (ECD-DBD) and donation after circulatory death (DCD) donors. However, these kidneys have inferior graft outcomes and lower rates of immediate function. Normothermic machine perfusion (NMP) may improve outcomes of these suboptimal donor kidneys. Previous non-randomized studies have shown the safety of this technique and suggested its efficacy in improving the proportion of immediate functioning kidneys compared to static cold storage (SCS). However, its additional value to hypothermic machine perfusion (HMP), which has already been proved superior to SCS, has not yet been established. Methods and analysis: This single-center, open-label, randomized controlled trial aims to assess immediate kidney function after 120 minutes additional, end-ischemic NMP compared to HMP alone. Immediate kidney function is defined as no dialysis treatment in the first week after transplant. Eighty recipients on dialysis at the time of transplant who receive an ECD-DBD or DCD kidney graft are eligible for inclusion. In the NMP group, the donor kidney is taken of HMP upon arrival in the recipient hospital and thereafter put on NMP for 120 minutes at 37 degrees Celsius followed by transplantation. In the control group, donor kidneys stay on HMP until transplantation. The primary outcome is immediate kidney function. Ethics and dissemination: The protocol has been approved by the Medical Ethical Committee of Erasmus Medical Center (2020-0366). Results of this study will be submitted to peer-reviewed journals. Registration: registered in clinicaltrials.gov (NCT04882254). Highlights: